BVA

(redirected from Best-Corrected Visual Acuity)
AcronymDefinition
BVABritish Veterinary Association (London, UK)
BVABoard of Veterans' Appeals
BVABritish Video Association
BVABlinded Veterans Association
BVABond Van Adverteerders (Dutch Association of Advertisers)
BVABoite Vitesse Automatique
BVABilling Validation Application
BVABusiness Value Analysis
BVABusiness Value Assessments
BVABoundary Value Analysis (test data)
BVABoston Vegan Association (Boston, MA)
BVABachelor of Visual Arts
BVABelle Vernon Area (Pennsylvania)
BVABritish Voice Association (UK)
BVABritish Voice Association (London, UK)
BVABoite de Vitesse Automatique (French: Automatic Gearbox)
BVABrian Vander Ark (singer)
BVABond van Vlaamse Architecten (Dutch: Association of Flemish Architects; Belgium)
BVABest-Corrected Visual Acuity
BVABusiness Value Added
BVABeirut Veterans of America
BVABettina Von Arnim Gymnasium
BVABrighton Volunteer Ambulance (New York)
BVABudget Versus Actual (financial reporting)
BVABudget Variance Analysis (finance)
BVABureau of Veterans' Appeals
BVABall-Valve Assembly (drilling industry)
BVABerufsverband der Augenärzte Deutschlands eV (German: Association of Ophthalmologists of Germany, Düsseldorf)
BVABidirectional Viterbi Algorithm
BVABuena Vista Academy
BVABrulé Ville et Associés (French polling agency)
BVABreach Variance Agreement
BVABest Value Assessment
BVABond Volunteer Aspirant
BVABarbarian Versus All (gaming, Diablo 2)
References in periodicals archive ?
Among total cases, 93% cases had improvement in their best-corrected visual acuity. Nd:YAG laser capsulotomy has minimal complications and is a safe and effective treatment procedure for complications associated with ECCE.
Caption: Figure 1: Best-corrected visual acuity (BCVA) and central retinal thickness (CRT) in eyes with diabetic macular edema (DME) treated with intravitreal antivascular endothelial growth factor (anti-VEGF) combined with prompt or deferred focal macular laser.
Caption: FIGURE 2: Changes in the mean best-corrected visual acuity (BCVA) expressed in logarithm of the minimum angle of resolution (log MAR) units before and after an intravitreal aflibercept (IVA) injection in eyes with a serous retinal detachment (SRD+) or without a SRD (SRD-).
The 15-patient, open-label, Phase 1/2 trial study used best-corrected visual acuity (BCVA), contrast sensitivity (CS), microperimetry for analysis of visual function, optical coherence tomography (OCT), and fundus autofluorescence (FAF) to measure the extent of the underlying geographic atrophy.
Early detection, timely treatment, and use of protective eyewear are the best ways to maintain eye health and prevent or delay vision impairment, defined as the best-corrected visual acuity <20/40 in the better-seeing eye (1).
Patients with best-corrected visual acuity less than 6/18.
Average best-corrected visual acuity of the remaining 3 patients was greater than 20/60.
Main outcome measures included incident cataract and visually significant AMD responsible for a reduction in best-corrected visual acuity to 20/30 or worse based on self-reports confirmed by medical record review.
The best-corrected visual acuity was counting fingers in the right eye and 20/20 in the left eye.
Eye examinations were conducted with annual fundus photographs and best-corrected visual acuity assessments.
Her best-corrected visual acuity was 20/400 in the right eye and 20/200 in the left.
Best-corrected visual acuity was 20/70, right eye (OD), and 20/30, left eye (OS).